Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroPoint Bioscience is a private medical diagnostics company focused on rapid point-of-care and near-patient testing systems built on MEMS and microfluidic lab-on-chip technology. The company develops, manufactures, and markets diagnostic instruments and consumable chips for medical and biomedical applications, with additional customization capabilities for research and applied testing markets. Its marketed platform brands include mLabs and qLabs, which are positioned for bedside and handheld/wireless testing with results available in minutes. Publicly available descriptions emphasize applications in cardiac markers, tumor-related testing, emergency care, and surgical monitoring, as well as broader uses in life science research, food safety, and environmental testing. The company appears to operate across both the United States and China, with headquarters presence in Santa Clara, California and operating/manufacturing activities in Shenzhen.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroPoint Bioscience.